ASTRO

A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Guselkumab Dose 1OngoingActive not recruitingPhase 3Open NCT05528510 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…